Nebius Group N.V. lands a $2B Nvidia deal to scale hyperscale AI cloud with Rubin/Vera/BlueField. Click for this NBIS stock update.

Company to Showcase HerResolve™ Non-Invasive Endometriosis Blood Test at Booth 604 BOSTON, MA, UNITED STATES, March 12, ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for ...

For decades, radiation decisions in early-stage invasive breast cancer have relied primarily on clinicopathologic features, which do not fully capture the biological behavior o ...

Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today the publication of results from a large, multi-institutional validation study of the ...